{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T11:23:46Z","timestamp":1774437826185,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,9,24]],"date-time":"2018-09-24T00:00:00Z","timestamp":1537747200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2018,9,24]],"date-time":"2018-09-24T00:00:00Z","timestamp":1537747200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR000445"],"award-info":[{"award-number":["UL1TR000445"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12891-018-2252-y","type":"journal-article","created":{"date-parts":[[2018,9,24]],"date-time":"2018-09-24T20:43:40Z","timestamp":1537821820000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Cyclic bisphosphonate therapy reduces pain and improves physical functioning in children with osteogenesis imperfecta"],"prefix":"10.1186","volume":"19","author":[{"given":"Melissa D.","family":"Garganta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah S.","family":"Jaser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margot A.","family":"Lazow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan G.","family":"Schoenecker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin","family":"Cobry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen R.","family":"Hays","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4189-6718","authenticated-orcid":false,"given":"Jill H.","family":"Simmons","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,9,24]]},"reference":[{"issue":"Suppl 2","key":"2252_CR1","first-page":"397","volume":"10","author":"M Ben Amor","year":"2013","unstructured":"Ben Amor M, Rauch F, Monti E, Antoniazzi F. Osteogenesis imperfecta. Pediatr Endocrinol Rev. 2013;10(Suppl 2):397\u2013405.","journal-title":"Pediatr Endocrinol Rev"},{"issue":"4","key":"2252_CR2","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.jpeds.2005.10.041","volume":"148","author":"C Land","year":"2006","unstructured":"Land C, Rauch F, Montpetit K, Ruck-Gibis J, Glorieux FH. Effect of intravenous pamidronate therapy on functional abilities and level of ambulation in children with osteogenesis imperfecta. J Pediatr. 2006;148(4):456\u201360.","journal-title":"J Pediatr"},{"issue":"6","key":"2252_CR3","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1359\/JBMR.050109","volume":"20","author":"AD Letocha","year":"2005","unstructured":"Letocha AD, Cintas HL, Troendle JF, Reynolds JC, Cann CE, Chernoff EJ, et al. Controlled trial of pamidronate in children with types III and IV osteogenesis imperfecta confirms vertebral gains but not short-term functional improvement. J Bone Miner Res. 2005;20(6):977\u201386.","journal-title":"J Bone Miner Res"},{"key":"2252_CR4","doi-asserted-by":"publisher","first-page":"540178","DOI":"10.4061\/2011\/540178","volume":"2011","author":"IM Ben Amor","year":"2011","unstructured":"Ben Amor IM, Glorieux FH, Rauch F. Genotype-phenotype correlations in autosomal dominant osteogenesis imperfecta. J Osteoporos. 2011;2011:540178.","journal-title":"J Osteoporos"},{"issue":"9418","key":"2252_CR5","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1016\/S0140-6736(04)16051-0","volume":"363","author":"F Rauch","year":"2004","unstructured":"Rauch F, Glorieux FH. Osteogenesis imperfecta. Lancet. 2004;363(9418):1377\u201385.","journal-title":"Lancet"},{"issue":"6","key":"2252_CR6","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1002\/ajmg.a.36545","volume":"164a","author":"FS Van Dijk","year":"2014","unstructured":"Van Dijk FS, Sillence DO. Osteogenesis imperfecta: clinical diagnosis, nomenclature and severity assessment. Am J Med Genet A. 2014;164a(6):1470\u201381.","journal-title":"Am J Med Genet A"},{"issue":"1","key":"2252_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1750-1172-8-154","volume":"8","author":"S Symoens","year":"2013","unstructured":"Symoens S, Malfait F. D\u2019hondt S, Callewaert B, Dheedene a, Steyaert W, et al. deficiency for the ER-stress transducer OASIS causes severe recessive osteogenesis imperfecta in humans. Orphanet J Rare Dis. 2013;8(1):1\u20136.","journal-title":"Orphanet J Rare Dis"},{"issue":"6","key":"2252_CR8","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.ajhg.2015.04.021","volume":"96","author":"R Mendoza-Londono","year":"2015","unstructured":"Mendoza-Londono R, Fahiminiya S, Majewski J, T\u00e9treault M, Nadaf J, Kannu P, et al. Recessive osteogenesis imperfecta caused by missense mutations in SPARC. Am J Hum Genet. 2015;96(6):979\u201385.","journal-title":"Am J Hum Genet"},{"issue":"9","key":"2252_CR9","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1080\/08035250510028722","volume":"94","author":"P Zack","year":"2005","unstructured":"Zack P, Franck L, Devile C, Clark C. Fracture and non-fracture pain in children with osteogenesis imperfecta. Acta Paediatr. 2005;94(9):1238\u201342.","journal-title":"Acta Paediatr"},{"issue":"2","key":"2252_CR10","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1203\/PDR.0b013e31815efd63","volume":"63","author":"P D'Eufemia","year":"2008","unstructured":"D'Eufemia P, Finocchiaro R, Celli M, Zambrano A, Tetti M, Villani C, et al. High levels of serum prostaglandin E2 in children with osteogenesis imperfecta are reduced by neridronate treatment. Pediatr Res. 2008;63(2):203\u20136.","journal-title":"Pediatr Res"},{"issue":"2","key":"2252_CR11","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1002\/ajmg.1320450211","volume":"45","author":"DE Cole","year":"1993","unstructured":"Cole DE. Psychosocial aspects of osteogenesis imperfecta: an update. Am J Med Genet. 1993;45(2):207\u201311.","journal-title":"Am J Med Genet"},{"issue":"3","key":"2252_CR12","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.jpain.2007.10.015","volume":"9","author":"A Huguet","year":"2008","unstructured":"Huguet A, Miro J. The severity of chronic pediatric pain: an epidemiological study. J Pain. 2008;9(3):226\u201336.","journal-title":"J Pain"},{"issue":"1","key":"2252_CR13","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1097\/BPO.0b013e3182a006a0","volume":"34","author":"T Sousa","year":"2014","unstructured":"Sousa T, Bompadre V, White KK. Musculoskeletal functional outcomes in children with osteogenesis imperfecta: associations with disease severity and pamidronate therapy. J Pediatr Orthop. 2014;34(1):118\u201322.","journal-title":"J Pediatr Orthop"},{"issue":"4","key":"2252_CR14","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.jbspin.2004.08.011","volume":"72","author":"V Forin","year":"2005","unstructured":"Forin V, Arabi A, Guigonis V, Filipe G, Bensman A, Roux C. Benefits of pamidronate in children with osteogenesis imperfecta: an open prospective study. Joint Bone Spine. 2005;72(4):313\u20138.","journal-title":"Joint Bone Spine"},{"issue":"4","key":"2252_CR15","doi-asserted-by":"publisher","first-page":"229","DOI":"10.2165\/00024677-200605040-00004","volume":"5","author":"JP Devogelaer","year":"2006","unstructured":"Devogelaer JP, Coppin C. Osteogenesis imperfecta : current treatment options and future prospects. Treat Endocrinol. 2006;5(4):229\u201342.","journal-title":"Treat Endocrinol"},{"issue":"12","key":"2252_CR16","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1002\/jbmr.2567","volume":"30","author":"T Palomo","year":"2015","unstructured":"Palomo T, Fassier F, Ouellet J, Sato A, Montpetit K, Glorieux FH, et al. Intravenous bisphosphonate therapy of young children with osteogenesis imperfecta: skeletal findings during follow up throughout the growing years. J Bone Miner Res. 2015;30(12):2150\u20137.","journal-title":"J Bone Miner Res"},{"issue":"14","key":"2252_CR17","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1056\/NEJM199810013391402","volume":"339","author":"FH Glorieux","year":"1998","unstructured":"Glorieux FH, Bishop NJ, Plotkin H, Chabot G, Lanoue G, Travers R. Cyclic administration of pamidronate in children with severe osteogenesis imperfecta. N Engl J Med. 1998;339(14):947\u201352.","journal-title":"N Engl J Med"},{"issue":"2","key":"2252_CR18","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1210\/jc.2010-0636","volume":"96","author":"LM Ward","year":"2011","unstructured":"Ward LM, Rauch F, Whyte MP, D'Astous J, Gates PE, Grogan D, et al. Alendronate for the treatment of pediatric osteogenesis imperfecta: a randomized placebo-controlled study. J Clin Endocrinol Metab. 2011;96(2):355\u201364.","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2252_CR19","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1359\/jbmr.090213","volume":"24","author":"F Rauch","year":"2009","unstructured":"Rauch F, Munns CF, Land C, Cheung M, Glorieux FH. Risedronate in the treatment of mild pediatric osteogenesis imperfecta: a randomized placebo-controlled study. J Bone Miner Res. 2009;24(7):1282\u20139.","journal-title":"J Bone Miner Res"},{"issue":"6","key":"2252_CR20","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1007\/s00431-018-3127-9","volume":"177","author":"A Tsimicalis","year":"2018","unstructured":"Tsimicalis A, Boitor M, Ferland CE, Rauch F, Le May S, Carrier JI, et al. Pain and quality of life of children and adolescents with osteogenesis imperfecta over a bisphosphonate treatment cycle. Eur J Pediatr. 2018;177(6):891\u2013902.","journal-title":"Eur J Pediatr"},{"issue":"9419","key":"2252_CR21","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1016\/S0140-6736(04)16101-1","volume":"363","author":"R Sakkers","year":"2004","unstructured":"Sakkers R, Kok D, Engelbert R, van Dongen A, Jansen M, Pruijs H, et al. Skeletal effects and functional outcome with olpadronate in children with osteogenesis imperfecta: a 2-year randomised placebo-controlled study. Lancet. 2004;363(9419):1427\u201331.","journal-title":"Lancet"},{"issue":"5","key":"2252_CR22","doi-asserted-by":"publisher","first-page":"e1168","DOI":"10.1542\/peds.2010-1609","volume":"126","author":"D Tomlinson","year":"2010","unstructured":"Tomlinson D, von Baeyer CL, Stinson JN, Sung L. A systematic review of faces scales for the self-report of pain intensity in children. Pediatrics. 2010;126(5):e1168\u201398.","journal-title":"Pediatrics"},{"issue":"8","key":"2252_CR23","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1097\/00005650-200108000-00006","volume":"39","author":"JW Varni","year":"2001","unstructured":"Varni JW, Seid M, Kurtin PS. PedsQL 4.0: reliability and validity of the pediatric quality of life inventory version 4.0 generic core scales in healthy and patient populations. Med Care. 2001;39(8):800\u201312.","journal-title":"Med Care"},{"issue":"6","key":"2252_CR24","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1367\/1539-4409(2003)003<0329:TPAAPP>2.0.CO;2","volume":"3","author":"JW Varni","year":"2003","unstructured":"Varni JW, Burwinkle TM, Seid M, Skarr D. The PedsQL 4.0 as a pediatric population health measure: feasibility, reliability, and validity. Ambul Pediatr. 2003;3(6):329\u201341.","journal-title":"Ambul Pediatr"},{"issue":"2","key":"2252_CR25","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1097\/00005650-199902000-00003","volume":"37","author":"JW Varni","year":"1999","unstructured":"Varni JW, Seid M, Rode CA. The PedsQL: measurement model for the pediatric quality of life inventory. Med Care. 1999;37(2):126\u201339.","journal-title":"Med Care"},{"issue":"4","key":"2252_CR26","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1067\/mpd.2003.137","volume":"142","author":"J Steelman","year":"2003","unstructured":"Steelman J, Zeitler P. Treatment of symptomatic pediatric osteoporosis with cyclic single-day intravenous pamidronate infusions. J Pediatr. 2003;142(4):417\u201323.","journal-title":"J Pediatr"},{"issue":"4","key":"2252_CR27","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1210\/en.2004-1167","volume":"146","author":"XH Liu","year":"2005","unstructured":"Liu XH, Kirschenbaum A, Yao S, Levine AC. Cross-talk between the interleukin-6 and prostaglandin E(2) signaling systems results in enhancement of osteoclastogenesis through effects on the osteoprotegerin\/receptor activator of nuclear factor-{kappa}B (RANK) ligand\/RANK system. Endocrinology. 2005;146(4):1991\u20138.","journal-title":"Endocrinology"},{"issue":"4","key":"2252_CR28","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1097\/01.pep.0000233023.33383.2b","volume":"18","author":"JR Engsberg","year":"2006","unstructured":"Engsberg JR, Ross SA, Collins DR. Increasing ankle strength to improve gait and function in children with cerebral palsy: a pilot study. Pediatr Phys Ther. 2006;18(4):266\u201375.","journal-title":"Pediatr Phys Ther"},{"issue":"6","key":"2252_CR29","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.otsr.2015.06.013","volume":"101","author":"X Bayle-Iniguez","year":"2015","unstructured":"Bayle-Iniguez X, Audouin-Pajot C, Sales de Gauzy J, Munzer C, Murgier J, Accadbled F. Complex regional pain syndrome type I in children. Clinical description and quality of life. Orthop Traumatol Surg Res. 2015;101(6):745\u20138.","journal-title":"Orthop Traumatol Surg Res"},{"issue":"3","key":"2252_CR30","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/AJP.0000000000000395","volume":"33","author":"T Nghiem","year":"2017","unstructured":"Nghiem T, Louli J, Treherne SC, Anderson CE, Tsimicalis A, Lalloo C, et al. Pain experiences of children and adolescents with osteogenesis imperfecta: an integrative review. Clin J Pain. 2017;33(3):271\u201380.","journal-title":"Clin J Pain"}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-018-2252-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12891-018-2252-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-018-2252-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T16:38:06Z","timestamp":1662136686000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmusculoskeletdisord.biomedcentral.com\/articles\/10.1186\/s12891-018-2252-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,24]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["2252"],"URL":"https:\/\/doi.org\/10.1186\/s12891-018-2252-y","relation":{},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,24]]},"assertion":[{"value":"30 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Institutional Review Board of Vanderbilt University. All participants (or guardians of participants aged <\u200918\u00a0years) provided written consent to participate. Participants < aged 18\u00a0years provided written assent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"344"}}